相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer
T. R. Sarkar et al.
ONCOGENE (2015)
Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog
Anurag N. Paranjape et al.
BMC CANCER (2014)
Zeb1 promotes androgen independence of prostate cancer via induction of stem cell-like properties
Ping Li et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2014)
Detection and Characterization of Invasive Circulating Tumor Cells Derived from Men with Metastatic Castration- Resistant Prostate Cancer
Terence W. Friedlander et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
The Mitogen-activated Protein ( MAP) Kinases p38 and Extracellular Signal-regulated Kinase ( ERK) Are Involved in Hepatocyte-mediated Phenotypic Switching in Prostate Cancer Cells
Bo Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Neuroendocrine Prostate Cancer: Subtypes, Biology, and Clinical Outcomes
Rahul Aggarwal et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2014)
Contributions of epithelial-mesenchymal transition and cancer stem cells to the development of castration resistance of prostate cancer
Ping Li et al.
MOLECULAR CANCER (2014)
Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer
Mercedes Marin-Aguilera et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition
Hiroki Tamaki et al.
ONCOTARGET (2014)
Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for intervention
Mannan Nouri et al.
FRONTIERS IN ONCOLOGY (2014)
FOXC2 Expression Links Epithelial-Mesenchymal Transition and Stem Cell Properties in Breast Cancer
Brett G. Hollier et al.
CANCER RESEARCH (2013)
Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity
Christine L. Chaffer et al.
CELL (2013)
Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation
Kouji Izumi et al.
EMBO MOLECULAR MEDICINE (2013)
Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial
William MacNee et al.
THORAX (2013)
Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells
M. R. Milone et al.
CELL DEATH & DISEASE (2013)
Overcoming mutation-based resistance to antiandrogens with rational drug design
Minna D. Balbas et al.
ELIFE (2013)
Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy
Yuting Sun et al.
CANCER RESEARCH (2012)
Clusterin Mediates TGF-β-Induced Epithelial-Mesenchymal Transition and Metastasis via Twist1 in Prostate Cancer Cells
Masaki Shiota et al.
CANCER RESEARCH (2012)
The PSA-/Io Prostate Cancer Cell Population Harbors Self-Renewing Long-Term Tumor-Propagating Cells that Resist Castration
Jichao Qin et al.
CELL STEM CELL (2012)
Modeling a Lethal Prostate Cancer Variant with Small-Cell Carcinoma Features
Vassiliki Tzelepi et al.
CLINICAL CANCER RESEARCH (2012)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Inhibition of p38 Mitogen-Activated Protein Kinase Improves Nitric Oxide-Mediated Vasodilatation and Reduces Inflammation in Hypercholesterolemia
Joseph Cheriyan et al.
CIRCULATION (2011)
Neuroendocrine Prostate Cancer Xenografts With Large-Cell and Small-Cell Features Derived From a Single Patient's Tumor: Morphological, Immunohistochemical, and Gene Expression Profiles
Ana Aparicio et al.
PROSTATE (2011)
Resistance to Docetaxel-Induced Apoptosis in Prostate Cancer Cells by p38/p53/p21 Signaling
Lu Gan et al.
PROSTATE (2011)
Kinase inhibitors: a new approach to rheumatoid arthritis treatment
Stanley Cohen et al.
CURRENT OPINION IN RHEUMATOLOGY (2010)
Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells
Meng-Lei Zhu et al.
FASEB JOURNAL (2010)
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
Joseph H. Taube et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Epithelial-to-Mesenchymal Transition and Cancer Stem Cells: A Coalition Against Cancer Therapies
Brett G. Hollier et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2009)
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
Ulrich Wellner et al.
NATURE CELL BIOLOGY (2009)
Hypoxia-associated p38 mitogen-activated protein kinase-mediated androgen receptor activation and increased HIF-1α levels contribute to emergence of an aggressive phenotype in prostate cancer
L. Khandrika et al.
ONCOGENE (2009)
CD44+CD24- prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis
E. M. Hurt et al.
BRITISH JOURNAL OF CANCER (2008)
Androgen receptor is a tumor suppressor and proliferator in prostate cancer
Yuanjie Niu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers
Sendurai A. Mani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
p38MAPK activation is involved in androgen-independent proliferation of human prostate cancer cells by regulating IL-6 secretion
Yohei Shida et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Integrative molecular concept modeling of prostate cancer progression
Scott A. Tomlins et al.
NATURE GENETICS (2007)
Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer
Joanne N. Davis et al.
CANCER RESEARCH (2006)
P38 MAPK protects against TNF-α-provoked apoptosis in LNCaP prostatic cancer cells
M. Ricote et al.
APOPTOSIS (2006)
Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells
L Patrawala et al.
ONCOGENE (2006)
Prospective identification of tumorigenic prostate cancer stem cells
AT Collins et al.
CANCER RESEARCH (2005)
被撤回的出版物: RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo (Retracted article. See vol. 295, pg. 13136, 2020)
SM Pulukuri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target
WK Kwok et al.
CANCER RESEARCH (2005)
分享论文
